OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
April 02, 2009
A review of recent product innovations, policy developments, and growth prospects in the excipients market.
The financial and economic downturn is likey to have long-term implications for outsourcing.
March 19, 2009
A bipartisan bill that would establish a regulatory pathway for the approval of biosimilars was introduced into the US House of Representatives last week.
March 12, 2009
The Synthetic Organic Chemical Manufacturers Association (SOCMA) said last week that Congress is likely to the include inherently safe technology (IST) measures in proposed chemical site-security legislation that is likely to be introduced in late winter or early spring.
March 06, 2009
Weakening fundamentals in 2008 and projected for 2009 dampen the outlook for pharmaceutical chemical outsourcing, but near-term growth and investments levels in R&D and capital spending remain fairly robust.
Gilles Cottier, SAFC's new president, plans to continue a growth strategy that emphasizes value-added technologies positions, growth in Asia, and customization in its supply-chain solutions.